Gram-Negative Bacilli in Wound Cultures: Likely Organisms
Gram-negative bacilli isolated from wound cultures most commonly represent Escherichia coli, Klebsiella species, Pseudomonas aeruginosa, and Acinetobacter species, with the specific organism depending on the wound type and clinical context.
Most Common Organisms by Frequency
The predominant gram-negative bacilli isolated from wound cultures include:
- E. coli is the most frequently isolated organism, accounting for approximately 31-36% of gram-negative bacilli from wounds 1, 2
- Klebsiella species (particularly K. pneumoniae) represent 9-21% of isolates 1, 2
- Pseudomonas aeruginosa accounts for 8-11% of wound isolates 1, 2
- Acinetobacter species (particularly A. baumannii) comprise approximately 13-14% of isolates, especially from surgical wounds 2
Context-Specific Considerations
Surgical Site Infections
For surgical site infections, the microbiology reflects endogenous flora or healthcare-associated pathogens 3. The gram-negative organisms typically originate from bowel or genitourinary flora, including coliforms and anaerobic bacteria 3.
Necrotizing Fasciitis
In necrotizing soft tissue infections, polymicrobial infections averaging 5 pathogens per wound are common, with gram-negative bacilli originating predominantly from bowel or genitourinary flora 3.
Bite Wounds and Special Exposures
- Human bite wounds involve mixed aerobic and anaerobic oral flora 4
- Salt-water exposure should raise suspicion for Vibrio species 4
- Fresh-water exposure may involve Aeromonas hydrophila 3
Intravenous Drug Users
Skin and soft tissue infections in this population may include typical wound pathogens plus organisms from contaminated injection materials 4.
Critical Antimicrobial Resistance Patterns
Extended-Spectrum Beta-Lactamase (ESBL) Producers
Approximately 28-35% of E. coli and Klebsiella isolates from wounds produce ESBLs, with K. pneumoniae showing the highest prevalence at 35% 1. These organisms demonstrate:
- Universal sensitivity to carbapenems (imipenem, meropenem) 1, 2
- High resistance to fluoroquinolones (ciprofloxacin 61%, levofloxacin 54% for E. coli) 2
- Significant resistance to third-generation cephalosporins, aminoglycosides, and co-trimoxazole 1
Carbapenem Resistance
Acinetobacter baumannii exhibits alarming resistance patterns with >70% resistance to fluoroquinolones, beta-lactam/beta-lactamase inhibitor combinations, ceftazidime, cefepime, and carbapenems 2. This organism shows multidrug resistance (MDR) rates of 60-80% and extensively drug-resistant (XDR) rates of 45-55% 2.
ICU vs. Non-ICU Settings
Gram-negative bacilli isolated from ICU patients demonstrate significantly higher resistance rates across all antimicrobial classes compared to non-ICU departments (p<0.05) 2.
Practical Clinical Approach
Specimen Collection
Avoid swabs whenever possible—submit tissue, fluids, or aspirates to optimize clinically relevant results 4. For infected wounds, collect tissue biopsies or aspirates using anaerobic transport conditions 4.
Empiric Coverage Considerations
Based on resistance patterns, the most reliable empiric options for gram-negative coverage in wounds include:
- Carbapenems maintain the lowest resistance rates (approximately 2% for E. coli) 2
- Amikacin shows relatively preserved activity 2
- Piperacillin-tazobactam demonstrates reasonable sensitivity 2
When to Suspect Specific Organisms
Look for these clinical clues:
- Crepitus or gas in tissues: Consider Clostridium species or gas-forming gram-negatives 3
- Severe systemic toxicity disproportionate to local findings: Suspect necrotizing infection with polymicrobial gram-negative involvement 3
- Foul-smelling discharge: Suggests anaerobic gram-negative bacilli 4
- Recent water exposure: Consider Aeromonas (fresh water) or Vibrio (salt water) 4, 3
Common Pitfalls
Do not assume enterococcal species are true pathogens when isolated from superficial surgical site cultures—they are commonly isolated but seldom pathogenic, and successful treatment regimens often exclude enterococcal coverage 4.
Fluoroquinolones should not be considered first-line empiric therapy given resistance rates exceeding 50-60% in E. coli 2.
Timing matters for bite wounds—there is no utility in collecting specimens at the time of the bite; only collect if infection develops 4.